Company intelligence / Profile preview

Elucidata

San Francisco, California, United Stateselucidata.io ↗

Ownership: Private
Employees: ~120
Development stage: Other

Overview

Elucidata does not conduct clinical trials or have clinical results. Its AI-powered Polly platform accelerates R&D by making multi-modal biomedical data machine learning-ready, supporting use cases such as target identification/validation, biomarker discovery, patient stratification, and translational research across pharma and biotech clients.

Therapeutic areas: Other
Modalities: Not directly applicable; company provides data platforms and AI tools for drug discovery, not therapeutics themselves.
Industry: Drug Discovery Services

Partnerships

Sapien Biosciences (strategic partnership to convert biobank assets into AI-ready multimodal data products)TetraScience (integration with scientific data cloud)Clients include major biopharma companies such as Pfizer and Janssen Pharmaceuticals.

Beyond the preview

Go deeper on Elucidata.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Elucidata.

Explore the full profile